Empowering scientist leaders through angel investing and VC co-investment
We are Scientist Investors
We fund pre-seed to Series A companies with deep tech in life sciences tools/services, biotechnology, and pharmaceuticals
We seek platforms that can create repeat/long-term value and are exponentially scalable
We rigorously evaluate founding teams
We reach beyond Silicon Valley and established biotech hubs
We can advise portfolio companies in both technical and strategic matters
Mika Lindvall, Ph.D.
Co-Founder COO
25+ therapeutic patent applications
Therapeutic and tech team lead. R&D manager.
Deal-sourcing analyst for dRx Capital
BD advising for Novartis, Recursion Therapeutics and BetterMeant Health
Accredited Investor: Startup Health, Altitude Lab, and Gaingels
Louis Metzger, Ph.D.
CO-Founder and CEO
Executive/Leadership (CSO of Tierra Biosciences)
Therapeutic and tech team lead. R&D manager, Novartis.
BD&L for Novartis Inst. for BioMedical Research (NIBR)
Scientific advisor to several startups
Mentor to SOSV IndieBio Incubator
How We Are Different
We are scientist investors with broad and deep technical insight
We find science and tech businesses that many VCs initially ignore
We can help our portfolio companies overcome operational challenges
We can access fresh geographies (Utah, New Mexico, Finland)
We have both insiders’ and outsiders’ perspectives:
As both scientists (~1% of VC founders) and LGBTQ are underrepresented
As first-time fund managers